TOKYO, Oct 14 (Reuters) - Japanese shares retreated on
Wednesday, following Wall Street's fall overnight as stalled
COVID-19 vaccine trials and lack of agreement on additional U.S.
fiscal stimulus weighed on market sentiment.
The benchmark Nikkei share average .N225 eased 0.05% to
23,589.35 by the midday break, while the broader Topix .TOPX
lost 0.51% to 1,640.69.
All but five of the 33 sector sub-indexes on the Tokyo
exchange traded lower, with airlines .IAIRL.T , iron and steel
.ISTEL.T and miners .IMING.T leading the decline on the main
bourse.
On Tuesday, major indexes on Wall Street ended lower as
Johnson & Johnson JNJ.N and Eli Lilly and Co LLY.N halted
coronavirus vaccine trials over safety concerns, dampening
investor sentiment. Fading hopes for a new U.S. coronavirus relief package were
also weighing on the market, as U.S. House Speaker Nancy Pelosi
rejected a $1.8 trillion coronavirus relief proposal from the
White House. Back home, Apple-related issues underperformed on
profit-taking and dented by a 2.7% fall in Apple Inc AAPL.O
shares following an event where the company unveiled its latest
iPhone.
Both TDK Corp 6762.T and Taiyo Yuden 6976.T fell about
0.9%, and Murata Manufacturing Corp 6981.T lost 0.63%.
Financial shares also took a hit from a weak performance in
their U.S. peers, with Sumitomo Mitsui Financial Group 8316.T
and Mitsubishi UFJ Financial Group 8306.T down about 1.7%
each, while Mizuho Financial Group 8411.T slipped 2.67%.
ANA Holdings 9202.T dipped 3.58% after reports that the
company was going to cut monthly wages for all workers by 5%.
Nippon Steel 5401.T lost 3.04% on news that the company
would sell two U.S. plants as it speeds up a reorganisation in
overseas operations.
Elsewhere, the Mothers Index .MTHR of start-up firms
gained 1.19%.
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Japan shares retreat as COVID-19 vaccine, U.S. stimulus hopes wane
Published 14/10/2020, 03:58
Japan shares retreat as COVID-19 vaccine, U.S. stimulus hopes wane
Latest comments
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.